SE0004840718
SE0004840718
Xvivo Perfusion AB
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 6.74B EUR | 8.18B EUR | 7.21B EUR |
Enterprise Value | 6.56B EUR | 7.99B EUR | 7.03B EUR |
Valuation Multiples | |||
Trailing P/E | 76.7x | 95.3x | 126.28x |
Forward P/E | 36.21x | -- | -- |
Price to Sales | 7.53x | 9.25x | 8.35x |
Price to Book | 3.06x | 3.72x | 3.33x |
EV/Revenue | 7.33x | 9.04x | 8.13x |
EV/EBITDA | 41.44x | 79.28x | 68.62x |
Price to FCF (P/FCF) | -- | 36.41x | 49.47x |
EV/FCF | -- | 35.6x | 48.2x |
FCF Yield | -0.43% | 2.75% | 2.02% |